Trials / Unknown
UnknownNCT03721055
Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor
18F-(2S,4R)4-Glutamine PET/CT in Imaging Patients With Malignant Tumor
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial studies positron emission tomography (PET) imaging utilizing 18F-(2S,4R)4-fluoroglutamine, a glutamic acid derivative, to image patients with malignant tumor. \[18F\]Fluoroglutamine PET may provide additional information that help diagnose and stage cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 18F-(2S,4R)4-fluoroglutamine | Undergo 18F-(2S,4R)4-fluoroglutamine PET/CT |
Timeline
- Start date
- 2017-08-21
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2018-10-26
- Last updated
- 2019-09-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03721055. Inclusion in this directory is not an endorsement.